FOXP2 and benign prostatic hyperplasia: The amounts of FOXP2 protein were evidently increased in primary prostate adenocarcinomas relative to the matched normal tissues and benign prostatic hyperplasia (BPH) samples (Figure 1—figure supplement 2A and B).